drugset / Trial / NCT00093093
Study of Viramidine to Ribavirin in Patients With Chronic Hepatitis C Who Are Treatment Naive
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine the safety and effectiveness of viramidine to ribavirin in chronic hepatitis C patients who have never before received treatment.
Timeline
- Start
- 2004-06
- Primary completion
- 2006-05
- Completion
- 2006-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ribavirin | Small molecule | 1000 mg | — |
| Subject | Ribavirin | Small molecule | 1200 mg | — |
| Subject | Taribavirin | Small molecule | 600 mg | — |
| Background | Peginterferon alfa-2a | Protein / enzyme biologic | — | — |